Andreas Neophytides

1.5k total citations
42 papers, 1.1k citations indexed

About

Andreas Neophytides is a scholar working on Neurology, Oncology and Organic Chemistry. According to data from OpenAlex, Andreas Neophytides has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 7 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Andreas Neophytides's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Parkinson's Disease and Spinal Disorders (10 papers) and Neurological disorders and treatments (8 papers). Andreas Neophytides is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Parkinson's Disease and Spinal Disorders (10 papers) and Neurological disorders and treatments (8 papers). Andreas Neophytides collaborates with scholars based in United States and Japan. Andreas Neophytides's co-authors include Abraham Lieberman, Govindan Gopinathan, Menek Goldstein, Alex Berenstein, Yasunari Niimi, Avi Setton, Daniel R. Weinberger, Lynn E. DeLisi, Richard Jed Wyatt and Morton Leibowitz and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Andreas Neophytides

42 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Neophytides United States 19 649 231 211 108 84 42 1.1k
A Muratorio Italy 18 423 0.7× 236 1.0× 223 1.1× 92 0.9× 53 0.6× 68 1.0k
R Hardie United Kingdom 15 693 1.1× 364 1.6× 125 0.6× 110 1.0× 51 0.6× 30 1.2k
Stuart Perlik United States 13 217 0.3× 168 0.7× 171 0.8× 66 0.6× 46 0.5× 16 575
C. Mawdsley United Kingdom 15 325 0.5× 165 0.7× 154 0.7× 65 0.6× 76 0.9× 25 760
Vittorio Govoni Italy 19 584 0.9× 254 1.1× 186 0.9× 185 1.7× 144 1.7× 35 1.1k
A. H. Rajput Canada 16 1.2k 1.8× 630 2.7× 145 0.7× 111 1.0× 32 0.4× 35 1.5k
G. J. A. Macphee United Kingdom 12 347 0.5× 164 0.7× 205 1.0× 61 0.6× 198 2.4× 24 746
Stefano Calzetti Italy 23 981 1.5× 433 1.9× 193 0.9× 240 2.2× 137 1.6× 58 1.4k
W. Poewe Germany 15 478 0.7× 165 0.7× 123 0.6× 144 1.3× 23 0.3× 49 826
Jacob I. Sage United States 19 687 1.1× 233 1.0× 71 0.3× 99 0.9× 17 0.2× 37 933

Countries citing papers authored by Andreas Neophytides

Since Specialization
Citations

This map shows the geographic impact of Andreas Neophytides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Neophytides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Neophytides more than expected).

Fields of papers citing papers by Andreas Neophytides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Neophytides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Neophytides. The network helps show where Andreas Neophytides may publish in the future.

Co-authorship network of co-authors of Andreas Neophytides

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Neophytides. A scholar is included among the top collaborators of Andreas Neophytides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Neophytides. Andreas Neophytides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neophytides, Andreas, Suliman Khan, & Eddie Louie. (1997). SUBACUTE CEREBELLITIS IN LYME DISEASE. International Journal of Clinical Practice. 51(8). 523–524. 9 indexed citations
2.
Niimi, Yasunari, Alex Berenstein, Avi Setton, & Andreas Neophytides. (1997). Embolization of Spinal Dural Arteriovenous Fistulae: Results and Follow-up. Neurosurgery. 40(4). 675–683. 157 indexed citations
3.
Lieberman, Abraham, et al.. (1990). Randomized Double-Blind Cross-Over Study of Sinemet-Controlled Release (CR4 50/200) versus Sinemet 25/100 in Parkinson’s Disease. European Neurology. 30(2). 75–78. 20 indexed citations
4.
Golbe, Lawrence I., Abraham Lieberman, Manfred D. Muenter, et al.. (1988). Deprenyl in the Treatment of Symptom Fluctuations in Advanced Parkinsonʼs Disease. Clinical Neuropharmacology. 11(1). 45–55. 94 indexed citations
5.
Fass, Daniel, et al.. (1987). Brain metastases from ovarian cancer. Journal of Neuro-Oncology. 5(3). 211–215. 25 indexed citations
6.
Lieberman, Abraham, Menek Goldstein, Govindan Gopinathan, & Andreas Neophytides. (1987). D-1 and D-2 Agonists in Parkinson's Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(S3). 466–473. 18 indexed citations
7.
Lieberman, Abraham, et al.. (1987). Deprenyl versus placebo in Parkinson disease: a double-blind study.. PubMed. 87(12). 646–9. 24 indexed citations
8.
Lieberman, Abraham, Govindan Gopinathan, Andreas Neophytides, & Menek Goldstein. (1986). Management of Levodopa Failures. Clinical Neuropharmacology. 9(2). S9–S21. 8 indexed citations
9.
Gopinathan, G, et al.. (1984). Pergolide and lisuride in advanced Parkinson's disease.. PubMed. 40. 503–7. 8 indexed citations
10.
Lieberman, Abraham, Menek Goldstein, Govindan Gopinathan, et al.. (1983). Further Studies with Lisuride in Parkinson’s Disease. European Neurology. 22(2). 119–123. 4 indexed citations
11.
Lieberman, Abraham, et al.. (1983). Bromocriptine and lisuride in Parkinson disease. Annals of Neurology. 13(1). 44–47. 15 indexed citations
12.
Weinberger, Daniel R., Lynn E. DeLisi, Andreas Neophytides, & Richard Jed Wyatt. (1981). Familial aspects of CT scan abnormalities in chronic schizophrenic patients. Psychiatry Research. 4(1). 65–71. 115 indexed citations
13.
Lieberman, Abraham, Menek Goldstein, Andreas Neophytides, et al.. (1981). Lisuride in Parkinson disease. Neurology. 31(8). 961–961. 27 indexed citations
14.
Lieberman, Abraham, Menek Goldstein, Morton Leibowitz, et al.. (1981). Lisuride combined with levodopa in advanced Parkinson disease. Neurology. 31(11). 1466–1466. 10 indexed citations
15.
Lieberman, A., et al.. (1980). Evaluation of Parkinson's disease.. PubMed. 23. 277–86. 20 indexed citations
16.
Kleinberg, David L., et al.. (1980). Pergolide Mesylate: A Potent Day-Long Inhibitor of Prolactin in Rhesus Monkeys and Patients with Parkinson's Disease*. The Journal of Clinical Endocrinology & Metabolism. 51(1). 152–154. 20 indexed citations
17.
Neophytides, Andreas, Paul F. Teychenné, Ronald F. Pfeiffer, & Donald B. Calne. (1979). Sodium Valproate in the Treatment of Cerebellar Disorders. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 6(4). 455–457. 3 indexed citations
18.
Lieberman, Abraham, Andreas Neophytides, Mark J. Kupersmith, et al.. (1979). Treatment of Parkinsonʼs disease with dopamine agonists: A review. The American Journal of the Medical Sciences. 278(1). 65–76. 12 indexed citations
19.
Calne, Donald B., Adrian C. Williams, John G. Nutt, et al.. (1978). Ergot Derivatives for Parkinsonism. The Medical Journal of Australia. 2(S2_Part2). 25–26. 7 indexed citations
20.
Tamminga, Carol A., Andreas Neophytides, Thomas N. Chase, & Lawrence A. Frohman. (1978). Stimulation of Prolactin and Growth Hormone Secretion by Muscimol, a γ-Aminobutyric Acid Agonist*. The Journal of Clinical Endocrinology & Metabolism. 47(6). 1348–1351. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Muratorio Breakdown of academic impact, for papers by R Hardie Breakdown of academic impact, for papers by Stuart Perlik Breakdown of academic impact, for papers by C. Mawdsley Breakdown of academic impact, for papers by Vittorio Govoni Breakdown of academic impact, for papers by A. H. Rajput Breakdown of academic impact, for papers by G. J. A. Macphee Breakdown of academic impact, for papers by Stefano Calzetti Breakdown of academic impact, for papers by W. Poewe Breakdown of academic impact, for papers by Jacob I. Sage
Rankless by CCL
2026